| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |